Analysts have a range of choices when valuing cannabis companies. Viridian commonly uses Discounted Cash Flow Analysis, Public Company Comparables, and M&A Precedent Transactions to value both small ...

Third-quarter earnings have been released for all companies in the Viridian Chart of the Week. Equity prices have had an opportunity to react to the news (or not). The orange line in the chart shows ...

WHEN THE GREENCARDS moved from Austin, the self-proclaimed "live music capital of the world," t o Nashville at the beginning of 2005, the string-band trio was making a conscious decision to shift its ...

In late 2022, Amgen (AMGN) announced it would acquire Horizon Therapeutics, and the announcement provided validation of Tepezza’s attractiveness as it accounted for a good part of the $28 billion ...

Across the recent three months, 10 analysts have shared their insights on Viridian Therapeutics (NASDAQ:VRDN), expressing a variety of opinions spanning from bullish to bearish. In the table below, ...